These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 24767381)
1. The effect of statins on cardiac allograft survival. Luo CM; Chou NK; Chi NH; Chen YS; Yu HY; Chang CH; Wang CH; Tsao CI; Wang SS Transplant Proc; 2014 Apr; 46(3):920-4. PubMed ID: 24767381 [TBL] [Abstract][Full Text] [Related]
2. Statin therapy is not associated with improved outcomes after heart transplantation in children and adolescents. Greenway SC; Butts R; Naftel DC; Pruitt E; Kirklin JK; Larsen I; Urschel S; Knecht K; Law Y J Heart Lung Transplant; 2016 Apr; 35(4):457-65. PubMed ID: 26746989 [TBL] [Abstract][Full Text] [Related]
3. Statins and the risk of cancer after heart transplantation. Fröhlich GM; Rufibach K; Enseleit F; Wolfrum M; von Babo M; Frank M; Berli R; Hermann M; Holzmeister J; Wilhelm M; Falk V; Noll G; Lüscher TF; Ruschitzka F Circulation; 2012 Jul; 126(4):440-7. PubMed ID: 22761452 [TBL] [Abstract][Full Text] [Related]
4. Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis. Townsend M; Khoury M; Koehl D; Kirklin JK; Cantor R; Beasley G; Chen CY; Boyle G; Parent JJ; Baez Hernandez N; Halnon N J Heart Lung Transplant; 2024 May; 43(5):703-713. PubMed ID: 38065240 [TBL] [Abstract][Full Text] [Related]
5. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. Mahle WT; Vincent RN; Berg AM; Kanter KR J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381 [TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiac allograft vasculopathy in heart and heart-lung transplantations: a 15-year retrospective study. Guihaire J; Mercier O; Flécher E; Aymami M; Fattal S; Chabanne C; Leroy Ladurie F; Lelong B; Cerrina J; Langanay T; Mussot S; Fabre D; De Latour B; Corbineau H; Verhoye JP; Dartevelle P; Leguerrier A; Fadel E J Heart Lung Transplant; 2014 Jun; 33(6):636-43. PubMed ID: 24630860 [TBL] [Abstract][Full Text] [Related]
16. The impact of mean first-year heart rate on outcomes after heart transplantation: does it make a difference? Shah AB; Patel JK; Rafiei M; Morrissey RP; Kittleson MM; Kobashigawa JA Clin Transplant; 2013; 27(5):659-65. PubMed ID: 23924048 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous heart and kidney transplantation for combined cardiac and renal failure. Wang SS; Chou NK; Chi NH; Hsu RB; Huang SC; Chen YS; Yu HY; Ko WJ; Chu SH; Tsai MK; Lee PH Transplant Proc; 2006 Sep; 38(7):2135-7. PubMed ID: 16980023 [TBL] [Abstract][Full Text] [Related]
18. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
19. Metaanalysis of statins and survival in de novo cardiac transplantation. Mehra MR; Raval NY Transplant Proc; 2004 Jun; 36(5):1539-41. PubMed ID: 15251380 [TBL] [Abstract][Full Text] [Related]
20. Heart retransplantation: the 25-year experience at a single institution. Smith JA; Ribakove GH; Hunt SA; Miller J; Stinson EB; Oyer PE; Robbins RC; Shumway NE; Reitz BA J Heart Lung Transplant; 1995; 14(5):832-9. PubMed ID: 8800717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]